HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX.
PROTONIX (pantoprazole sodium) delayed-release tablets, for oral use
PROTONIX (pantoprazole sodium) for delayed-release oral suspension
Initial U.S. approval: 2000
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
PROTONIX is a proton pump inhibitor (PPI) indicated for the following:
DOSAGE AND ADMINISTRATION
See full prescribing information for administration instructions
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
Most common adverse reactions are:
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See full prescribing information for a list of clinically important drug interactions (7)
USE IN SPECIFIC POPULATIONS
Pregnancy: Based on animal data, may cause fetal harm. (8.1)
See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.
PROTONIX® (pantoprazole sodium) Highlights
No Current Announcements.
Report an Adverse Event